BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18371060)

  • 1. CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.
    Huh HJ; Chae SL; Lee M; Hong KS; Mun YC; Seong CM; Chung WS; Huh JW
    Int J Lab Hematol; 2009 Jun; 31(3):344-51. PubMed ID: 18371060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.
    Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H
    Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
    Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
    Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
    Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
    Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
    Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
    Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
    Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].
    Xu HZ; Li A; Yu Y; Li JF; Liu X; Wang XH; Wang X; Xu GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1308-11. PubMed ID: 19099633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
    Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
    Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
    Zuo Y; Cheng Y; Zhang L; Qin Y; Luo H
    Hematology; 2019 Dec; 24(1):480-486. PubMed ID: 31210595
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
    Feng BZ; Lei JL; Han JZ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
    Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
    Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
    Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
    Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of hypoplastic myelodysplastic syndrome].
    Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
    Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance].
    Yang SM; Lu SF; Fei XM; Zhang JF; Shen WY; Li JY; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1560-3. PubMed ID: 21176370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.